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Background: Chylothorax after congenital heart surgery is not an uncommon com-
plication, and it is associated with significant morbidity. However, consensus treatment 
guidelines are lacking. To improve the treatment outcomes of patients with postoperative 
chylothorax, we implemented a standardized management protocol at Severance Hospi-
tal in September 2014.
Methods: A retrospective review of patients treated at a single center was done. All cor-
rective and palliative operations for congenital heart disease performed at our institution 
between January 2008 and April 2018 were reviewed. The incidence and treatment out-
comes of postoperative chylothorax were analyzed.
Results: The incidence of chylothorax was 1.9%. Sixty-one percent of the patients could 
be managed with a low-fat diet, while 28% of the patients required complete restriction of 
enteral feeding. Thoracic duct embolization was performed in 2 patients and chest tube 
drainage decreased immediately after the procedure. No patient required thoracic duct 
ligation or pleurodesis. After implementation of the institutional management protocol, 
the number of chest tube drainage days decreased (median, 24 vs. 14 days; p=0.45).
Conclusion: Implementing a strategy to reduce postoperative chylothorax resulted in 
an acceptable incidence of postoperative chylothorax. Instituting a clinical practice proto-
col helped to curtail the treatment duration and to decrease the requirement for surgical 
treatment. Image-guided embolization of the thoracic duct is an effective treatment for 
postoperative chylothorax.
Keywords: Chylothorax, Congenital heart defects, Postoperative complication, Postop-
erative care
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Introduction
Postoperative chylothorax after surgical procedures for 
congenital heart disease poses a challenging clinical situa-
tion. Its incidence varies across centers, with a reported 
range from 2% to 5% [1-4]. Postoperative chylothorax is as-
sociated with poor nutrition, an electrolyte imbalance, and 
a higher risk of thrombus development, and its clinical im-
pact includes increased mortality, increased length of hos-
pital stay, increased length of intensive care unit stay, pro-
longed mechanical ventilation, and a higher likelihood of 
extracorporeal membrane oxygenation support [4].
From a surgical perspective, the mechanism of postoper-
ative chylothorax can be categorized as traumatic or 
non-traumatic. Traumatic chylothorax is caused by direct 
injury of the thoracic duct or one of its lymphatic branch-
es. Non-traumatic chylothorax is caused by unfavorable 
hemodynamics, lymphatic malformation, or congenital 
syndromes such as Noonan syndrome and Turner syn-
drome. Traditionally, treatment options included diet 
modification and octreotide infusion as conservative man-
agement, and thoracic duct ligation and pleurodesis as sur-
gical management [5-7]. In recent years, new imaging mo-
dalities such as magnetic resonance lymphangiography 
have improved our understanding of chylothorax, and 
studies on thoracic duct embolization demonstrated an ac-






Although many treatment options for postoperative chy-
lothorax exist, there is no generally accepted standardized 
treatment guideline. At Severance Hospital, a standardized 
man agement protocol for postoperative chylothorax was 
developed and has been implemented since September 
2014. The aim of this study was to determine the incidence 
of postoperative chylothorax after surgery for congenital 
heart disease and to evaluate the efficacy of implementing 
a chylothorax management protocol.
Methods
Patients
This is a retrospective review of experiences at a single 
center. The medical records of all patients who underwent 
corrective or palliative operations for congenital heart dis-
ease at Severance Hospital from January 2008 to April 2018 
were reviewed. This study was reviewed and approved by 
the Institutional Review Board (IRB approval no., 4-2019-
0903). The obligation to obtain informed consent was 
waived by the institutional review board in view of the ret-
rospective nature of the study.
Diagnosis of chylothorax
Chylothorax was suspected when persistent drainage 
from an existing chest tube became cloudy when the pa-
tient was fed, or when similar milky fluid was found after 
placing a tube into a newly discovered effusion. The diag-
nosis of chylothorax was confirmed based on the charac-
teristics of the pleural f luid recovered from each patient. 
Chylothorax was diagnosed if any of the following criteria 
was met: (1) the pleural f luid triglyceride level was >100 
mg/dL, (2) the percentage of lymphocytes in the pleural 
f luid was >80%, or (3) the pleural f luid triglyceride level 
was higher than that of the serum.
Postoperative chylothorax was defined as chylothorax 
developing within 30 days of surgery. Based on the maxi-
mum cumulative output of all chest tubes for a 24-hour 
period, chylothorax was classified high (≥20 mL/kg/day) or 
low (<20 mL/kg/day). The recurrence of chylothorax was 
diagnosed when a drainage tube was re-inserted for chy-
lous effusion. Chylothorax duration was defined as the 
time interval from the day of diagnosis to the day of chest 
tube removal.
Institutional policy to reduce postoperative 
chylothorax
To minimize the development of postoperative chylotho-
rax, we follow our institutional policy. During the opera-
tion, we do not remove the thymus routinely. Even in neo-
nates or for aortic arch repair, we preserve the thymus 
whenever possible. If the thymus is large, by splitting its 
left and right lobes and retracting the lobes with pericardi-
al tenting sutures, good exposure of the aortic arch and 
pulmonary arteries can be obtained. Cannulation of the 
innominate artery for selective cerebral perfusion can be 
carried out without thymus resection. Dissection of the 
aortic arch and superior vena cava (SVC) is minimized if 
not indicated. We routinely place a SVC drainage cannula 
through the right atrium and avoid direct cannulation of 
the SVC. The indications for direct SVC cannulation are 
superior cavopulmonary anastomosis and anomalous pul-
monary venous connection to the SVC.
The postoperative management policies are as follows: (1) 
early removal of the central venous catheter, (2) avoidance 
of hyperalimentation, and (3) therapy to lower the SVC 
pressure in patients with physiologically high SVC pressure 
(e.g., those who have undergone a Fontan operation or re-
ceived bidirectional cavopulmonary shunt), which includes 
diuresis, pulmonary toileting, supplemental oxygen, pul-
monary vasodilator use, nitric oxide inhalation, and after-
load reduction.
Management protocol for postoperative 
chylothorax
As a quality improvement program, we established a 
standardized management protocol for postoperative chy-
lothorax. The protocol was developed over 3 months, in-
cluding a period of literature review and gathering the 
opinions of multidisciplinary team of experts, after which 
it was implemented in September 2014. The protocol was 
then revised in 2017 (Fig. 1).
Based on the chest tube drainage amount, the patients 
are classified as having low- or high-output chylothorax, 
according to which a different initial management strategy 
is applied. The diet of patients with low-output chylothorax 
is modified to a medium-chain triglyceride (MCT) or low-
fat diet. In patients with high-output chylothorax, early 
adoption of nil per os (NPO) with total parenteral nutri-
tion (TPN) treatment is applied. Surgical thoracic duct li-
gation, intravenous infusion of octreotide, and pleurodesis 
are sequentially considered as treatment options for 
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non-responders. The version of the protocol revised in 
2017 incorporates lymphangiography and thoracic duct 
embolization as the first choice of treatment modality for 
adult-sized patients. For the NPO and TPN treatment 
groups, enteral intake of water, a glucose-water solution, or 
a balanced ion solution with no fat components is allowed.
Lymphangiography and thoracic duct embolization are 
performed by interventional radiologists. Inguinal lymph 
nodes are accessed under real-time ultrasound guidance 
with a 25-gauge needle, and lymphangiography is per-
formed using an oil-based contrast agent (Lipiodol; Guer-
bet, Bloomington, IN, USA). After visualization of the tho-
racic duct and identification of a target lymphatic vessel, a 
21-gauge long Chiba needle is placed in the target lymphat-
ic vessel under fluoroscopic guidance. Next, a microcathe-
ter is placed in the lymphatic vessel and contrast dye is in-
jected to identify the chylous leak. The thoracic duct is 
embolized with an embolization coil and/or a mixture of 
cyanoacrylate (Histoacryl; B. Braun, Barcelona, Spain) and 
Lipiodol (Guerbet).
Statistical analysis
The incidence of chylothorax was calculated for all cor-
rective or palliative surgical procedures for congenital 
heart disease. Continuous variables were summarized as 
median with range. Categorical and ordinal variables were 
presented as frequency and percentage. Group compari-
NPO+TPN
+octreotide at 3 mcg/kg/hr
for 7 additional days
Continue MCT for 8 weeks from
initiation or from last surgical
intervention
MCT diet for 7 days
Chest tube output
<10 mL/kg/day
Low volume chylous output
(<20 mL/kg/day)
High volume chylous output
(>20 mL/kg/day)
Glucose water feeding
+TPN for 7 days
Chest tube output decreased?
(<10 mL/kg/day)
NPO+TPN for 7 10 days
+octreotide at 3 mcg/kg/hr
Chest tube output decreased?
(<10 mL/kg/day)
Thoracic duct ligation
NPO+TPN for 3 additional days
Chest tube output decreased?
(<10 mL/kg/day)
Chest tube output decreased?
(<10 mL/kg/day)
Consider pleurodesis












Fig. 1. Management protocol for 
postoperative chylothorax for chil-
dren (A) and adults (B). MCT, medi-
um chain triglyceride; NPO, nil per 
os; TPN, total parenteral nutrition. 





sons were made using the Wilcoxon rank sum test. All 
p-values <0.05 were considered to indicate statistical sig-
nificance. Statistical analysis was performed using IBM 
SPSS ver. 23.0 (IBM Corp., Armonk, NY, USA).
Results
Incidence of postoperative chylothorax
There were 2,465 corrective or palliative surgical proce-
dures in the study period, and 46 patients developed post-
operative chylothorax. The incidence was 1.9%. In 16 pa-
tients (35%), chylothorax developed after postoperative day 
7. In 15 patients (33%), the chest tube drainage was classi-
fied as high-output (>20 mL/kg/day). The characteristics of 
the patients are summarized in Table 1.
NPO+TPN
+octreotide at 3 mcg/kg/hr
for 7 additional days
Chylous output
Thoracic duct embolization
Chest tube output decreased?
(<100 mL/day)
NPO+TPN for 7 10 days
+octreotide at 3 mcg/kg/hr
Chest tube output decreased?
(<100 mL/day)
Thoracic duct ligation
NPO+TPN for 3 additional days
Chest tube output decreased?
(<100 mL/day)
Chest tube output decreased?
(<100 mL/day)
Consider pleurodesis
NPO+TPN for 3 additional days
Continue MCT for 8 weeks
from initiation or from
last surgical intervention




















Fig. 1. (Continued; caption shown 
on previous page).
Table 1. Characteristics of patients with postoperative chylothorax 
(n=46)
Characteristic Variable
Male sex 29 (63)
Age at operation 2.7 mo (1 day–46 yr)
Body weight (kg) 4.7 (2.6–107)
Single ventricle 12 (26)
Timing of chylothorax occurrence (day)
   <3 7 (15)
   3–7 23 (50)
   >7 16 (35)
Output of chyle
   High output (>20 mL/kg/day) 15 (33)
   Low output (≤20 mL/kg/day) 31 (67)
Values are presented as number (%) or median (range).
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Twenty-six percent of cases of postoperative chylothorax 
occurred in patients with a functional single ventricle. The 
incidence of postoperative chylothorax was markedly high-
er after repair of a vascular ring (3 of 11, 27%), the Fontan 
operation (5 of 21, 24%), and the Norwood operation (2 of 
10, 20%) than after other procedures (Table 2).
Treatment modalities
In 28 patients (61%), the chylothorax could be managed 
with only an MCT or low-fat diet. Restriction of food ex-
cept for water or a glucose-water solution was required in 
13 patients (27%). Intravenous somatostatin was adminis-
tered in 4 patients (9%). Lymphangiography and thoracic 
duct embolization were performed in 2 adult patients, in 
whom chest tube drainage decreased immediately after the 
procedure. No patient required surgical thoracic duct liga-
tion or pleurodesis. Data on the treatment modalities, chy-
lothorax duration, and hospital stay are summarized in 
Table 3.
Percutaneous thoracic duct embolization was performed 
in 2 patients, and it was effective for controlling the chy-
lous drainage (Fig. 2). A 46-year-old woman was diagnosed 
with postoperative chylothorax on postoperative day 16 af-
Table 2. Incidence of postoperative chylothorax based on type of 





   Ventricular septal defect repair 9 (1)
   Coarctation of the aorta repair 2 (4)
   Systemic to pulmonary artery shunt 3 (9)
   Arterial switch operation 1 (2)
   Bidirectional cavopulmonary shunt 3 (5)
   Fontan operation 5 (24)
   Norwood operation 2 (20)
   Vascular ring repair 3 (27)
   Total anomalous pulmonary venous 
connection repair
3 (10)
   Tetralogy of Fallot repair 4 (9)
   Others 11 (1)
RACHS category
   I 4 (9)
   II 19 (41)
   III 18 (39)
   IV 2 (4)
   V 0
   IV 2 (4)
   Not categorized 1 (2)
RACHS, risk adjustment for congenial heart surgery.








MCT or low-fat diet 44 (96)
MCT or low-fat diet only 28 (61) 9 (6–49) 23 (7–331)
Nil per os 13 (28) 17 (3–66) 28 (15–93)
Octreotide 4 (9) 35 (17–196) 50 (22–196)
Lymphangiography and 
thoracic duct embolization
2 (4) 6 (5–6) 37 (21–38)
Thoracic duct ligation 0
Pleurodesis 0
Protocol based approach 20 (43) 14 (6–39) 21 (9–184)
Values are presented as median (range), unless otherwise stated.
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ter the repair of pulmonary valve stenosis. On postopera-
tive day 18, lymphangiography and thoracic duct emboli-
zation were carried out. Her chest tube drainage decreased 
from 1,500 mL/day pre-procedure to 200 mL/day on the 
day after the procedure. The chest tube was removed 3 
days after thoracic duct embolization. The other patient 
was a 20-year-old man who underwent vascular ring re-
pair. His chest tube drainage was 2,300 mL/day despite full 
restriction of enteral intake, but decreased to 510 and 110 
mL/day on post-procedure days 1 and 2. There were no 
procedure-related complications or recurrence of chylotho-
rax.
Comparison of clinical outcomes before and after 
implementation of the treatment protocol
The median chest tube drainage duration of all chy-
lothorax patients was 20 days (range, 6–196 days). In our 
cohort of 46 patients with postoperative chylothorax, 26 
(57%) were diagnosed before September 2014, when our 
management protocol was implemented. The number of 
chest tube drainage days decreased after implementation of 
the protocol (median, 24 versus 14 days; p=0.045). The 
length of hospital stay also decreased (median, 37 versus 21 
days; p=0.067), with marginal statistical significance. Chy-
lothorax recurred in 2 patients both before and after im-
plementation of the protocol (p=0.78). There were 2 in-hos-
pital deaths in the pre-implantation period, whereas no 
in-hospital mortality occurred in the post-implementation 
period (p=0.20) (Table 4).
Discussion
In our patient cohort, the incidence of postoperative chy-
lothorax for congenital heart surgery was 1.9%. This is 
lower than has been reported in other previous reports [1-
4]. Therefore, we think that our intraoperative and postop-
erative management strategy to reduce postoperative chy-
lothorax is effective. To prevent traumatic damage to 
lymphatic channels, we minimize the dissection of the 
structures around the lymphatic pathway. In neonates and 
infants, the thymus is normally large, which limits the ex-
posure of the great vessels. The fissure between the left and 
right lobes of the thymus can be easily dissected, and later-
al retraction of the right and left lobes with pericardial 
tenting provides good exposure of the aortic arch and the 
branch pulmonary arteries. In most cases, neonatal aortic 
arch repair or repair of tetralogy of Fallot can be per-
formed without resection of the thymus. Another surgical 
precaution is dissection around the SVC. To avoid dissec-
tion around the SVC, we do not directly cannulate the SVC 
unless indicated. The SVC is directly cannulated only for 
repair of an anomalous pulmonary venous connection to 
the SVC or superior cavopulmonary anastomosis. Creation 
of a superior cavopulmonary connection or a Fontan pro-
cedure leads to elevated SVC pressure and can result in 
lymph leakage. These operations are known to be high-risk 
procedures for postoperative chylothorax. In our cohort, 
24% of the patients developed chylothorax after the Fontan 
operation, but the incidence was only 5% after placement 
of a bidirectional cavopulmonary shunt. This suggests that 
our strategy of minimal intraoperative dissection and post-
operative SVC pressure-lowering management is effective 
for reducing the incidence of chylothorax. In our cohort, 
35% of the cases of chylothorax developed later than post-
operative day 7. This suggests that non-traumatic causes 
are an important factor in chylothorax development. In 
this regard, postoperative management is also important to 
prevent postoperative chylothorax. Central venous lines 
should be removed as early as possible [11] and medical 
management should have the goal of hemodynamic stabili-
ty and lowering the central venous pressure.
Protocol-based management has been proposed to im-
prove the outcomes of chylothorax, and studies have shown 
that implementing such management strategies led to re-
ductions in chest tube utilization time and improvements 
in clinical outcomes [12-14]. We developed a management 
protocol and implemented it in September 2014. The num-
ber of chest tube utilization days decreased (median, 24 to 
14 days; p=0.045), and the length of hospital stay also de-
creased (median, 37 to 21 days; p=0.067). There was no 
significant difference in in-hospital mortality or the recur-
rence of chylothorax. Even before implementing the proto-
col, physicians at our institution treated the patients in a 













Amount (mL/kg/day) 18 (1.0–115) 13 (0.9–79) 0.48
Chylothorax 
duration (day)
24 (6–196) 14 (6–39) 0.045
Hospital stay (day) 37 (7–331) 21 (9–184) 0.067




Values are presented as median (range), unless otherwise stated.
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similar way to that described in the protocol. However, the 
protocol more specifically stipulated the relevant details, 
which helped to decrease the variability in practice among 
physicians and led to a shortened treatment duration.
Recently, percutaneous lymphatic embolization has been 
reported as a successful treatment option for patients with 
postoperative chylothorax [10]. In our cohort, lymphangi-
ography and interventional thoracic duct embolization 
were performed in 2 patients. These patients were adults 
who underwent vascular ring repair and pulmonary valve 
replacement. In both patients, the daily chest tube drainage 
was more than 1,500 mL, but after embolization, the chy-
lous drainage decreased immediately and the chest tubes 
could be removed in 4 days. Based on our experience, we 
revised our management protocol to consider lymphangi-
ography and lymphatic embolization as the first treatment 
option in adult-sized patients. Our experience is limited to 
adults, but according to the case series published by Savla 
et al. [10], lymphatic embolization was successfully per-
formed in young infants, suggesting new possibilities for 
chylothorax treatment, even for younger patients.
The main limitation of this study is that it presents a ret-
rospective analysis of a limited number of patients. We 
compared clinical outcomes between before and after the 
implementation of the treatment protocol. The protocol 
helped to decrease variability in practice, but the manage-
ment of patients did not always strictly adhere to the pro-
tocol. Each patient’s characteristics and medical conditions 
influenced small details of the management. With the ac-
cumulation of more data and advances in medical practice, 
the protocol should be revised further to obtain the best 
treatment results for this postoperative problem.
In conclusion, the utilization of a strategy to reduce post-
operative chylothorax after surgical procedures for con-
genital heart disease resulted in an acceptably low inci-
dence. Implementation of a standardized treatment 
protocol for postoperative chylothorax helped to reduce the 
treatment duration and to improve treatment outcomes. A 
strategy focusing on protocol-guided conservative manage-
ment and image-guided embolization of the thoracic duct 
helped to reduce the need for surgical treatment for post-
operative chylothorax.
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